Krystal Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Revenue	373.16	290.52	50.7	-	-	-	Upgrade
Revenue Growth (YoY)	54.51%	473.02%	-	-	-	-	Upgrade
Cost of Revenue	21.41	20.06	3.09	-	-	-	Upgrade
Gross Profit	351.76	270.45	47.61	-	-	-	Upgrade
Selling, General & Admin	136.64	113.69	98.4	78.84	41.99	15.06	Upgrade
Research & Development	56.77	53.57	46.43	42.46	27.88	17.94	Upgrade
Operating Expenses	193.41	167.26	144.83	121.3	69.88	33	Upgrade
Operating Income	158.35	103.2	-97.23	-121.3	-69.88	-33	Upgrade
Interest Expense	-	-	-	-	-1.49	-	Upgrade
Interest & Investment Income	28.6	29.66	22.62	5.22	0.2	0.83	Upgrade
EBT Excluding Unusual Items	186.95	132.86	-74.6	-116.08	-71.17	-32.17	Upgrade
Gain (Loss) on Sale of Assets	-	-	100	-	-	-	Upgrade
Legal Settlements	-	-37.5	-12.5	-25	-	-	Upgrade
Pretax Income	186.95	95.36	12.9	-139.98	-69.57	-32.17	Upgrade
Income Tax Expense	-11.96	6.2	1.97	-	-	-	Upgrade
Net Income	198.91	89.16	10.93	-139.98	-69.57	-32.17	Upgrade
Net Income to Common	198.91	89.16	10.93	-139.98	-69.57	-32.17	Upgrade
Net Income Growth	279.80%	715.58%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	29	29	27	25	22	19	Upgrade
Shares Outstanding (Diluted)	30	30	28	25	22	19	Upgrade
Shares Change (YoY)	1.34%	7.16%	8.87%	14.85%	18.15%	18.15%	Upgrade
EPS (Basic)	6.89	3.12	0.40	-5.49	-3.13	-1.71	Upgrade
EPS (Diluted)	6.66	3.00	0.39	-5.49	-3.13	-1.71	Upgrade
EPS Growth	275.72%	669.23%	-	-	-	-	Upgrade
Free Cash Flow	165.59	119.18	-100.6	-153.55	-116.27	-40.93	Upgrade
Free Cash Flow Per Share	5.54	4.01	-3.63	-6.02	-5.24	-2.18	Upgrade
Gross Margin	94.26%	93.09%	93.90%	-	-	-	Upgrade
Operating Margin	42.43%	35.52%	-191.77%	-	-	-	Upgrade
Profit Margin	53.30%	30.69%	21.56%	-	-	-	Upgrade
Free Cash Flow Margin	44.37%	41.02%	-198.43%	-	-	-	Upgrade
EBITDA	159.67	105.66	-93.32	-118.65	-67.11	-31.15	Upgrade
EBITDA Margin	42.79%	36.37%	-184.07%	-	-	-	Upgrade
D&A For EBITDA	1.33	2.47	3.91	2.64	2.77	1.85	Upgrade
EBIT	158.35	103.2	-97.23	-121.3	-69.88	-33	Upgrade
EBIT Margin	42.43%	35.52%	-191.77%	-	-	-	Upgrade
Effective Tax Rate	-	6.50%	15.24%	-	-	-	Upgrade

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q